NCT07720440

Brief Summary

This prospective randomized controlled trial evaluated the effect of nociception level (NOL) index-guided intraoperative analgesia on postoperative pain management in patients undergoing elective cesarean section under general anesthesia. Sixty patients were randomly assigned to either NOL-guided analgesia or standard intraoperative monitoring. The primary outcome was postoperative pain intensity assessed using the visual analog scale (VAS) during the first 24 hours after surgery. Secondary outcomes included postoperative opioid requirements and time to first breastfeeding. The study aimed to determine whether objective intraoperative nociception monitoring could improve postoperative analgesia and enhance early maternal recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2024

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

July 18, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
Last Updated

July 22, 2026

Status Verified

July 1, 2026

Enrollment Period

6 months

First QC Date

July 18, 2026

Last Update Submit

July 18, 2026

Conditions

Keywords

Nociception Level IndexNOL IndexIntraoperative AnalgesiaCesarean SectionGeneral AnesthesiaPostoperative PainOpioid ConsumptionBreastfeedingNociception Monitoring

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain intensity assessed using the Visual Analog Scale (VAS)

    Postoperative pain intensity was evaluated using a 10-cm Visual Analog Scale (VAS), where 0 indicated no pain and 10 indicated the worst imaginable pain.

    10 minutes, 30 minutes, 4 hours, 8 hours, 12 hours, and 24 hours after surgery

Secondary Outcomes (1)

  • Time to first breastfeeding

    Within the first postoperative hour

Other Outcomes (1)

  • Need for rescue analgesia

    Within the first 24 hours after surgery

Study Arms (2)

NOL-Guided Analgesia Group

EXPERIMENTAL

Patients undergoing elective cesarean section under general anesthesia were monitored intraoperatively using the Nociception Level (NOL) index in addition to standard monitoring. After fetal delivery, fentanyl was administered in 25-mcg boluses when the NOL value remained above 25 for more than 1 minute, with a minimum interval of 5 minutes between doses.

Device: Nociception Level Index Monitoring

Standard Monitoring Group

ACTIVE COMPARATOR

Patients undergoing elective cesarean section under general anesthesia received standard intraoperative monitoring. Intraoperative analgesic management was performed according to conventional clinical practice without NOL index guidance.

Other: Standard Intraoperative Monitoring

Interventions

Standard intraoperative monitoring was used for routine anesthetic and analgesic management without NOL index guidance.

Standard Monitoring Group

The Nociception Level (NOL) index was used to guide intraoperative fentanyl administration after fetal delivery.

NOL-Guided Analgesia Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients undergoing elective cesarean section under general anesthesia.
  • Ability to provide written informed consent.

You may not qualify if:

  • Refusal to participate.
  • Emergency cesarean section.
  • High-risk pregnancy (including hypertensive disorders of pregnancy, diabetes mellitus, preterm labor, or fetal growth restriction).
  • Placental abnormalities.
  • History of allergy to any study medication.
  • History of malignant hyperthermia.
  • Alcohol or substance abuse.
  • Severe cardiac disease or severe arrhythmia.
  • Peripheral vascular disease.
  • Renal or hepatic failure.
  • Contraindication to corticosteroid administration.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences Türkiye Haseki Training and Research Hospital

Istanbul, Sultangazi, 34256, Turkey (Türkiye)

Location

MeSH Terms

Conditions

AgnosiaPain, PostoperativeBreast Feeding

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPainFeeding BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned in a 1:1 ratio to either a Nociception Level (NOL) index-guided analgesia group or a standard intraoperative monitoring group. Both groups underwent elective cesarean section under general anesthesia using the same anesthetic protocol. In the intervention group, fentanyl administration after fetal delivery was guided by the NOL index, whereas in the control group analgesia was managed according to conventional clinical practice based on standard hemodynamic monitoring.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc.Prof

Study Record Dates

First Submitted

July 18, 2026

First Posted

July 22, 2026

Study Start

August 15, 2023

Primary Completion

February 15, 2024

Study Completion

February 15, 2024

Last Updated

July 22, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations